Influenza


Studies from T. Betakova et al add new findings in the area of influenza



Influenza Library
Library Home

This article was published in Virus Weekly, which you can subscribe to online.

2007 NOV 20 -- According to recent research published in the Journal of General Virology, "The 115 residue CM2 protein of influenza C virus is a structural homologue of the M2 protein of influenza A virus. Expression of the CM2 protein in Xenopus oocytes showed that it can form a voltage-activated ion channel permeable to Cl-."

"To investigate whether the CM2 protein has pH modulating activity comparable to that of the M2 protein, CM2 was co-expressed with a pH-sensitive haemagglutinin (HA) from influenza A virus. The results indicate that, like the M2 protein, the CM2 protein has a capacity to reduce the acidity of the exocytic pathway and reduce conversion of the pH-sensitive HA to its low pH conformation during transport to the cell surface. By contrast, the NB protein of influenza B virus has no detectable activity," wrote T. Betakova and colleagues.

The researchers concluded: "Although, the pH modulating activity of the CM2 protein was substantially less than that of the M2 protein, these observations provide support for a role in virus uncoating analogous to that of M2."

Betakova and colleagues published their study in the Journal of General Virology (Evidence that the CM2 protein of influenza C virus can modify the pH of the exocytic pathway of transfected cells. Journal of General Virology, 2007;88(Part 8):2291-2296).

For additional information, contact T. Betakova, Slovaks Academy Science, Institute Virology, Dubravska Cesta 9, Bratislava 84505, Slovakia.

The publisher's contact information for the Journal of General Virology is: Society General Microbiology, Marlborough House, Basingstoke Rd., Spencers Woods, Reading RG7 1AG, Berks, England.

Keywords: Slovakia, Bratislava, Flu, Influenza.

This article was prepared by Virus Weekly editors from staff and other reports. Copyright 2007, Virus Weekly via NewsRx.com.